Manila Times Business
Ultragenyx to Participate at Goldman Sachs 47th Annual Global Healthcare Conference
NOVATO, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil Kakkis, M.D., Ph.D., the company's president and chief executive officer will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9, 2026, at 4:00 PM ET. The live and archiv
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Israel, Lebanon agree to conditional ceasefire
2h ago
Quantinuum Announces Pricing of Upsized Initial Public Offering
3h ago
Origin Energy and Landis+Gyr bring large-scale smart gas technology to Australian homes and businesses
3h ago
Compal and Datasection Advance AI Infrastructure for the Production Era
3h ago